Home / Products / Peptides / Tirzepatide (10mg)
Tirzepatide (10mg)
Third-party tested Tirzepatide research peptide — dual GIP/GLP-1 agonist, ≥99.3% HPLC purity, CoA included. For laboratory research only.
Batch PL-TRZ-2601
Certificate of Analysis available
Product Overview
Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, originally developed to study incretin biology and metabolic regulation. As one of the fastest-growing research peptide categories, dual-incretin agonists like Tirzepatide are being studied in laboratory models of glucose homeostasis, insulin secretion, adipose tissue regulation, and beta-cell function. Prime Labs' Tirzepatide research peptide is synthesised via solid-phase peptide synthesis (SPPS), purified by preparative HPLC to ≥99.3% purity, and identity-verified by high-resolution mass spectrometry. Each batch is independently tested by an accredited third-party laboratory, and a batch-matched Certificate of Analysis (CoA) is included with every order. Supplied strictly for in-vitro laboratory research — not for human or veterinary use.
Frequently Asked Questions
Specifications
- Purity
- ≥99.3% (HPLC verified)
- Molecular Form
- Lyophilized powder
- Storage
- -20°C, protect from light
- Vial Size
- 10mg
- Reconstitution
- Bacteriostatic water (research use)
- CoA
- Included with every batch
Lab Results
Batch PL-TRZ-2601 verified at 99.3% purity by independent laboratory testing.
Download Certificate of AnalysisFrequently Purchased Together
Customer Reviews
Based on 176 verified reviews
No written reviews yet for this batch — be the first to share your research findings.
